Varian books $87m order on Maryland proton therapy center
Neuronetics raises $34m for anti-depression device
Neuronetics said it raised $34.3 million in an equity offering slated to help broaden the use of its anti-depression device that relies on magnetic stimulation of the brain.
Navidea lands $60m for Lymphoseek
Diabetes: BD wins FDA nod for infusion set
ResMed shares dive on apnea trial results
Autonomic Technologies raises $38m in Series D round
Robot-assisted surgery: Hansen Medical pares losses
Diabetes: Debiotech takes out option on iSense
Switzerland’s Debiotech wants to blend continuous glucose monitoring technology made by an Oregon outfit into its JewelPump disposable insulin patch pump, a move toward a functioning artificial pancreas.
The Lausanne-based company announced an option to grab exclusive rights to CGM intellectual property developed by iSense CGM of Wilsonville, Ore.
GPOs: Premier says ACA is pushing providers toward value-based healthcare
PAD: Intact Vascular touts 1st-in-human results
Intact Vascular said a 1st-in-human study of a device designed to repair arterial dissections after angioplasty has produced encouraging results.